Results 11 to 20 of about 1,379,743 (300)
Breast: Ductal carcinoma [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2013 Classification Invasive ductal carcinoma is a heterogeneous group with many different subtypes, some of them extremely rare. Each of these variants is associated with another pathological presentation and with a different prognosis compared to invasive ductal carcinoma of no special type (NST).
Moelans, CB, van, Diest PJ
core +7 more sources
Ductal carcinoma in situ of the breast [PDF]
BMJ, 2012 #### Summary points Ductal carcinoma in situ (DCIS) is a preinvasive (also termed non-invasive) breast cancer, where proliferations of malignant ductal epithelial cells remain confined within intact breast ducts (fig 1⇓). DCIS is a precursor lesion that has the potential to transform into an invasive cancer over a timescale that may be a few years or ...
Nicola L P, Barnes +3 more
openaire +4 more sources
Ductal carcinoma in situ of the breast [PDF]
Indian Journal of Surgery, 2013 Ductal carcinoma in situ (DCIS) of the breast is a potentially invasive neoplasm. Risk factors include high estrogen states such as use of oral contraceptive (OC) pills, nulliparity, advanced age at first birth, and also family history and genetic mutations. The incidence of this usually clinically silent condition has risen in the past few decades due
Melvin J. Silverstein, Michael D. Lagios
openaire +3 more sources
Breast invasive ductal carcinoma diagnosis using machine learning models and Gabor filter method of histology images [PDF]
, 2023 Breast cancer is the most common type of cancer in women and the leading cause of death from a malignant growth in the world. Machine learning methods have been created to help with cancer detection accuracy.
Rania R. Kadhim +3 more
core +1 more source
Breast Ductal Carcinoma In Situ [PDF]
International Journal of Surgical Oncology, 2012 Ductal carcinoma in situ (DCIS) of the breast is becoming one of the most important diseases diagnosed in preventive medicine screening. The current age-adjusted incidence rate of DCIS is 32.5 per 100,000 women. For women 50–64 years of age, the incidence is approximately 88 per 100,000. Currently, for every 4 diagnoses of invasive breast cancer, there
Sacchini, Virgilio +5 more
openaire +2 more sources
A transfer learning-based system for grading breast invasive ductal carcinoma [PDF]
, 2023 Breast carcinoma is a sort of malignancy that begins in the breast. Breast malignancy cells generally structure a tumour that can routinely be seen on an x-ray or felt like a lump.
Radhakrishnan Sujatha +5 more
core +1 more source
A new model for ductal carcinoma in situ suggests strategies for treatment [PDF]
, 2002 Human ductal carcinoma in situ (DCIS) of the breast is now diagnosed quite frequently, due largely to the introduction of mammographic screening. It has been shown in a cell culture system that activation of c-erbB-2, but not the epidermal growth factor ...
Gullick, William J.
core +1 more source
Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast [PDF]
, 2015 Glutathione S-transferase Pi (GST P) has been reported to be a marker of dysplastic lesions. For this reason expression of GST P by intraduct breast carcinoma was evaluated by immunohistochemistry. Thirty-seven of 92 carcinomas (40%) were GST P positive.
Bellamy, C O, Harrison, D J
core +2 more sources
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma [PDF]
, 2007 Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopathological parameters, coexpression of other biological markers and prognosis.
de Bock, G. H. +10 more
core +2 more sources
The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. [PDF]
, 2008 Approximately 1 in every 600 women attending breast-screening programmes in the United Kingdom is diagnosed with breast carcinoma in situ (BCIS). However, there is little information on the occurrence of subsequent cancers (other than second breast ...
Holmberg, L +9 more
core +1 more source